Quotient Therapeutics
London
About Quotient Therapeutics
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $50.0M
- Funding stage: Seed
- Last round: Seed (Nov 2023)
- Website: quotient-tx.com
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/quotient-therapeutics-15244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.